FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912292511> ?p ?o ?g. }

• W2912292511 endingPage "108" @default.
• W2912292511 startingPage "97" @default.
• W2912292511 abstract "Accumulating evidence suggests that epidermal growth factor receptor (EGFR) plays a role in the progression of pulmonary arterial hypertension (PAH). Clinically-approved epidermal growth factor inhibitors such as gefitinib, erlotinib, and lapatinib have been explored for PAH. However, None of them were able to attenuate PAH. So, we explored the role of dacomitinib, a new pan-EGFR inhibitor, in PAH. Adult male Sprague-Dawley rats were used to study hypoxia- or monocrotaline-induced right ventricular remodeling as well as systolic function and hemodynamics using echocardiography and a pressure-volume admittance catheter. Morphometric analyses of lung vasculature and pressure-volume vessels were performed. Immunohistochemical staining, flow cytometry, and viability, as well as scratch-wound, and Boyden chamber migration assays were used to identify the roles of dacomitinib in pulmonary artery smooth muscle cells (PASMCs). The results revealed that dacomitinib has a significant inhibitory effect on the thickening of the media, adventitial collagen increased. Dacomitinib also has a significant role in attenuating pulmonary artery pressure and right ventricular hypertrophy. Additionally, dacomitinib inhibits hypoxia-induced proliferation, migration, autophagy and cell cycle progression through PI3K-AKT-mTOR signaling in PASMCs. Our study indicates that dacomitinib inhibited hypoxia-induced cell cycle progression, proliferation, migration, and autophagy of PASMCs, thereby attenuating pulmonary vascular remodeling and development of PAH via the PI3K-AKT-mTOR signaling pathway. Overall, dacomitinib may serve as new potential therapeutic for the treatment of PAH." @default.
• W2912292511 created "2019-02-21" @default.
• W2912292511 creator A5001215714 @default.
• W2912292511 creator A5002974065 @default.
• W2912292511 creator A5002986160 @default.
• W2912292511 creator A5006063221 @default.
• W2912292511 creator A5006921213 @default.
• W2912292511 creator A5010253350 @default.
• W2912292511 creator A5011026788 @default.
• W2912292511 creator A5024808619 @default.
• W2912292511 creator A5034605417 @default.
• W2912292511 creator A5055543806 @default.
• W2912292511 creator A5057304430 @default.
• W2912292511 creator A5060565764 @default.
• W2912292511 creator A5067939471 @default.
• W2912292511 date "2019-05-01" @default.
• W2912292511 modified "2023-10-16" @default.
• W2912292511 title "Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension" @default.
• W2912292511 cites W1938603543 @default.
• W2912292511 cites W1974262159 @default.
• W2912292511 cites W2006178366 @default.
• W2912292511 cites W2006771504 @default.
• W2912292511 cites W2007073167 @default.
• W2912292511 cites W2007649418 @default.
• W2912292511 cites W2016305001 @default.
• W2912292511 cites W2017240600 @default.
• W2912292511 cites W2020528128 @default.
• W2912292511 cites W2026882881 @default.
• W2912292511 cites W2027216014 @default.
• W2912292511 cites W2038922683 @default.
• W2912292511 cites W2045826243 @default.
• W2912292511 cites W2054134591 @default.
• W2912292511 cites W2091742630 @default.
• W2912292511 cites W2096223780 @default.
• W2912292511 cites W2100986426 @default.
• W2912292511 cites W2102604313 @default.
• W2912292511 cites W2109049969 @default.
• W2912292511 cites W2110841878 @default.
• W2912292511 cites W2110938265 @default.
• W2912292511 cites W2120498387 @default.
• W2912292511 cites W2160570327 @default.
• W2912292511 cites W2166224440 @default.
• W2912292511 cites W2169047384 @default.
• W2912292511 cites W2169963968 @default.
• W2912292511 cites W2295630803 @default.
• W2912292511 cites W2563471914 @default.
• W2912292511 cites W2574765964 @default.
• W2912292511 cites W2611112690 @default.
• W2912292511 cites W2724281455 @default.
• W2912292511 cites W2736966475 @default.
• W2912292511 cites W2764117127 @default.
• W2912292511 cites W2982366104 @default.
• W2912292511 cites W2988610037 @default.
• W2912292511 doi "https://doi.org/10.1016/j.ejphar.2019.02.008" @default.
• W2912292511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30753867" @default.
• W2912292511 hasPublicationYear "2019" @default.
• W2912292511 type Work @default.
• W2912292511 sameAs 2912292511 @default.
• W2912292511 citedByCount "22" @default.
• W2912292511 countsByYear W29122925112019 @default.
• W2912292511 countsByYear W29122925112020 @default.
• W2912292511 countsByYear W29122925112021 @default.
• W2912292511 countsByYear W29122925112022 @default.
• W2912292511 countsByYear W29122925112023 @default.
• W2912292511 crossrefType "journal-article" @default.
• W2912292511 hasAuthorship W2912292511A5001215714 @default.
• W2912292511 hasAuthorship W2912292511A5002974065 @default.
• W2912292511 hasAuthorship W2912292511A5002986160 @default.
• W2912292511 hasAuthorship W2912292511A5006063221 @default.
• W2912292511 hasAuthorship W2912292511A5006921213 @default.
• W2912292511 hasAuthorship W2912292511A5010253350 @default.
• W2912292511 hasAuthorship W2912292511A5011026788 @default.
• W2912292511 hasAuthorship W2912292511A5024808619 @default.
• W2912292511 hasAuthorship W2912292511A5034605417 @default.
• W2912292511 hasAuthorship W2912292511A5055543806 @default.
• W2912292511 hasAuthorship W2912292511A5057304430 @default.
• W2912292511 hasAuthorship W2912292511A5060565764 @default.
• W2912292511 hasAuthorship W2912292511A5067939471 @default.
• W2912292511 hasConcept C121608353 @default.
• W2912292511 hasConcept C126322002 @default.
• W2912292511 hasConcept C178790620 @default.
• W2912292511 hasConcept C185592680 @default.
• W2912292511 hasConcept C2778087573 @default.
• W2912292511 hasConcept C2779438470 @default.
• W2912292511 hasConcept C2780580887 @default.
• W2912292511 hasConcept C2780940725 @default.
• W2912292511 hasConcept C502942594 @default.
• W2912292511 hasConcept C540031477 @default.
• W2912292511 hasConcept C62478195 @default.
• W2912292511 hasConcept C71924100 @default.
• W2912292511 hasConcept C75217442 @default.
• W2912292511 hasConcept C7836513 @default.
• W2912292511 hasConcept C86554907 @default.
• W2912292511 hasConcept C86803240 @default.
• W2912292511 hasConcept C95444343 @default.
• W2912292511 hasConcept C98274493 @default.
• W2912292511 hasConceptScore W2912292511C121608353 @default.
• W2912292511 hasConceptScore W2912292511C126322002 @default.

• next